
Holland & Knight continues to build its bench strength in the region by poaching lateral partners from native Pennsylvania firms with the addition of the recently departed co-chair of Buchanan Ingersoll & Rooney’s class action litigation practice.
Kenneth Racowski officially joined Holland & Knight’s Philadelphia office on May 10, though the firm announced his arrival this week. He said he moved to the Florida-born firm to provide his clients a broader geographic platform.
Mr. Racowski’s most recent trials have involved antitrust issues, including a three-week trial in federal court of a competitor action alleging group boycott and information exchange claims and an eight-week trial against Federal Trade Commission (FTC) allegations of anti-competitive conduct.
“Ken is a highly regarded litigator known for his success in the defense and trial of commercial disputes throughout the United States,” said John Toriello, leader of Holland & Knight’s New York and Philadelphia Litigation Group. “His significant experience in antitrust matters, as well as in commercial and healthcare litigation, complement our existing strengths in these areas. He is an outstanding addition to our team.”
“We are delighted that Ken has decided to join Holland & Knight,” added David Kully, the head of Holland & Knight’s Antitrust Team. “He is an accomplished antitrust litigator who will provide great value to our clients that are facing competition issues.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas